Chargement en cours...
Clinical effectiveness and safety of low cost versus innovator brand amlodipine in hypertension: A single-blinded, randomized, crossover, noninferiority trial
OBJECTIVES: A single-blinded, randomized, crossover, noninferiority trial was conducted to evaluate clinical effectiveness and safety of low-cost brand (LCB) versus innovator brand (IB) amlodipine in essential hypertension. MATERIALS AND METHODS: The primary end-point was change of systolic blood pr...
Enregistré dans:
| Publié dans: | Indian J Pharmacol |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Medknow Publications & Media Pvt Ltd
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155474/ https://ncbi.nlm.nih.gov/pubmed/28066111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0253-7613.194844 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|